Learn More About:

Osteoarthritis of the Knee

Ampio is developing Ampion™ for the treatment of osteoarthritis of the knee.


Diabetic Macular Edema

Ampio is developing Optina™ for the treatment of Diabetic Macular Edema.

AMPE Stock Quote - delayed
Last Change
AMPE 5.73 Down 0.05 (0.87%)

Ampio News

04/22/2014 | Press Release

Luoxis Awarded Health Canada Approval for RedoxSYSTM Diagnostic System

04/21/2014 | Press Release

Ampio Pharmaceuticals’ Vyrix Files Registration Statement for Proposed Initial Public Offering

04/10/2014 | Press Release

Ampio Pharmaceuticals’ Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane™ in Canada and Other Territories to Broaden its International Footprint

» See all Ampio news